UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 136

Sortiert nach

Quantitative Analysis of Conebeam CT for Delineating Stents in Stent-Assisted Coil Embolization

American journal of neuroradiology : AJNR, 2018-03, Vol.39 (3), p.488-493

2018

Volltextzugriff (PDF)

Good Clinical Response to Gefitinib in a Non-small Cell Lung Cancer Patient Harboring a Rare Somatic Epidermal Growth Factor Gene Point Mutation; Codon 768 AGC > ATC in Exon 20 (S768I)

Japanese journal of clinical oncology, 2010-11, Vol.40 (11), p.1105-1109

2010

Volltextzugriff (PDF)

4024 POSTER Customized Chemotherapy on the Basis of EGFR Mutation Status for Elderly Patients With Advanced Non-Small-Cell Lung Cancer

European journal of cancer (1990), 2011, Vol.47, p.S280-S280

2011

Volltextzugriff (PDF)

9143 POSTER Expressions of IGF-1R and IGFBP3 in Advanced Non-small Cell Lung Cancer (NSCLC)

European journal of cancer (1990), 2011, Vol.47, p.S636-S636

2011

Volltextzugriff (PDF)

Correlation between programmed death-ligand 1 (PD-L1) expression and T790M status in EGFR-mutant non-small cell lung cancer (NSCLC)

Annals of oncology, 2016-10, Vol.27, p.vi428-vi428

2016

Volltextzugriff (PDF)

Gene delivery with biocompatible cationic polymer: Pharmacogenomic analysis on cell bioactivity

Biomaterials, 2007-12, Vol.28 (34), p.5169-5175

2007

Volltextzugriff (PDF)

441P Bevacizumab (BEV) combination chemotherapies (CCTs) for patients (Pts) with high-risk factors of pulmonary hemorrhage (PH) in advanced non-small cell lung cancer (NSCLC)

Annals of oncology, 2015-12, Vol.26, p.ix125-ix125

2015

Volltextzugriff (PDF)

451PD Osimertinib at 80 mg for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer

Annals of oncology, 2016-12, Vol.27 (suppl_9)

2016

Volltextzugriff (PDF)

451PD Osimertinibat 80mg for refractoryleptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer

Annals of oncology, 2016-12, Vol.27, p.ix145-ix145

2016

Volltextzugriff (PDF)

Egfr-Tyrosine Kinase Inhibitor (Tki) Rechallenge with Bevacizumab in Egfr-Mutant Non-Small Cell Lung Cancer (Nsclc)

Annals of oncology, 2014-09, Vol.25, p.iv452

2014

Volltextzugriff (PDF)

1286PEGFR-TYROSINE KINASE INHIBITOR (TKI) RECHALLENGE WITH BEVACIZUMAB IN EGFR-MUTANT NON-SMALL CELL LUNG CANCER (NSCLC)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv452-iv453

2014

Volltextzugriff (PDF)

9028 Genetic polymorphisms of the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer treated with platinum-based doublet chemotherapy

European journal of cancer supplements, 2009, Vol.7 (2), p.513-514

2009

Volltextzugriff (PDF)

Population pharmacokinetics and pharmacogenomics of erlotinib: Effect of drug exposure on treatment outcomes in Japanese patients with non-small cell lung cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.2549-2549

2011

Volltextzugriff (PDF)

Retrospective analysis of Japanese patients with relapse or refractory small-cell lung cancer (SCLC) treated with amrubicin hydrochloride

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e18088-e18088

2010

Volltextzugriff (PDF)

A phase II study of gefitinib versus vinorelbine or gemcitabine in chemotherapy-naïve elderly patients with advanced non-small cell lung cancer based on epidermal growth factor receptor mutation status

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.7559-7559

2010

Volltextzugriff (PDF)

Long-term survival in a patient with small-cell lung cancer undergoing hemodialysis who received multiple courses of chemotherapy

Japanese journal of clinical oncology, 2011-04, Vol.41 (4), p.582-585

2011

Volltextzugriff (PDF)

Breast-conserving therapy for ductal carcinoma in situ

Oncology reports, 2001-07, Vol.8 (4), p.835

2001

Volltextzugriff (PDF)

Lobar emphysema due to ductus arteriosus compressing right upper bronchus in an infant with congenital heart disease

The Annals of thoracic surgery, 2003-04, Vol.75 (4), p.1308-1310

2003

Volltextzugriff (PDF)

Phase I/II study of weekly docetaxel in patients with previously treated non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7243-7243

2004

Volltextzugriff (PDF)

Phase I/II study of weekly docetaxel in patients with previously treated non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7243-7243

2004

Volltextzugriff (PDF)

ACTIVATION ANALYSIS OF TRACE ELEMENTS IN THE HUMAN BLOOD SERUM OF SOME SPECIFIC DISEASES

Proceedings of the First International Workshop Neuherberg, Federal Republic of Germany, April 1980, 2021, Vol.1, p.365-380

2021

Volltextzugriff (PDF)

Neutron activation analysis of Japanese standard rocks

Journal of Radioanalytical Chemistry, 1980-03, Vol.59 (1), p.245-248

1980

Volltextzugriff (PDF)

Anesthetic management for neonates with congenital cystic adenomatoid malformation

Masui. The Japanese journal of anesthesiology, 2000-07, Vol.49 (7), p.750

2000

Volltextzugriff (PDF)

Success rate of anesthesia induction using target-controlled infusion of propofol with fentanyl

Masui. The Japanese journal of anesthesiology, 1999-03, Vol.48 (3), p.256

1999

Volltextzugriff (PDF)

Assessment of future flood inundations under climate and land use change scenarios in the Ciliwung River Basin, Jakarta

Journal of flood risk management, 2018-02, Vol.11 (S2), p.S1105-S1115

2018

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(122)

Publikationsform

Sprache

Englisch
(132)
Japanisch
(36)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quantitative Analysis of Conebeam CT for Delineating Stents in Stent-Assisted Coil Embolization

Good Clinical Response to Gefitinib in a Non-small Cell Lung Cancer Patient Harboring a Rare Somatic Epidermal Growth Factor Gene Point Mutation; Codon 768 AGC > ATC in Exon 20 (S768I)

4024 POSTER Customized Chemotherapy on the Basis of EGFR Mutation Status for Elderly Patients With Advanced Non-Small-Cell Lung Cancer

9143 POSTER Expressions of IGF-1R and IGFBP3 in Advanced Non-small Cell Lung Cancer (NSCLC)

Correlation between programmed death-ligand 1 (PD-L1) expression and T790M status in EGFR-mutant non-small cell lung cancer (NSCLC)

Gene delivery with biocompatible cationic polymer: Pharmacogenomic analysis on cell bioactivity

441P Bevacizumab (BEV) combination chemotherapies (CCTs) for patients (Pts) with high-risk factors of pulmonary hemorrhage (PH) in advanced non-small cell lung cancer (NSCLC)

451PD Osimertinib at 80 mg for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer

451PD Osimertinibat 80mg for refractoryleptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer

Egfr-Tyrosine Kinase Inhibitor (Tki) Rechallenge with Bevacizumab in Egfr-Mutant Non-Small Cell Lung Cancer (Nsclc)

1286PEGFR-TYROSINE KINASE INHIBITOR (TKI) RECHALLENGE WITH BEVACIZUMAB IN EGFR-MUTANT NON-SMALL CELL LUNG CANCER (NSCLC)

9028 Genetic polymorphisms of the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer treated with platinum-based doublet chemotherapy

Population pharmacokinetics and pharmacogenomics of erlotinib: Effect of drug exposure on treatment outcomes in Japanese patients with non-small cell lung cancer

Retrospective analysis of Japanese patients with relapse or refractory small-cell lung cancer (SCLC) treated with amrubicin hydrochloride

A phase II study of gefitinib versus vinorelbine or gemcitabine in chemotherapy-naïve elderly patients with advanced non-small cell lung cancer based on epidermal growth factor receptor mutation status

Long-term survival in a patient with small-cell lung cancer undergoing hemodialysis who received multiple courses of chemotherapy

Breast-conserving therapy for ductal carcinoma in situ

Lobar emphysema due to ductus arteriosus compressing right upper bronchus in an infant with congenital heart disease

Phase I/II study of weekly docetaxel in patients with previously treated non-small cell lung cancer (NSCLC)

Phase I/II study of weekly docetaxel in patients with previously treated non-small cell lung cancer (NSCLC)

ACTIVATION ANALYSIS OF TRACE ELEMENTS IN THE HUMAN BLOOD SERUM OF SOME SPECIFIC DISEASES

Neutron activation analysis of Japanese standard rocks

Anesthetic management for neonates with congenital cystic adenomatoid malformation

Success rate of anesthesia induction using target-controlled infusion of propofol with fentanyl

Assessment of future flood inundations under climate and land use change scenarios in the Ciliwung River Basin, Jakarta

Suchergebnisse filtern